COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Jenneke Leentjens(Radboud University Nijmegen), Saskia Middeldorp(Amsterdam UMC Location University of Amsterdam), Thijs F. van Haaps(Amsterdam University Medical Centers), Roger E. G. Schutgens(Utrecht University), Pieter Wessels(University of Pretoria)
Cited by 237
Related Papers
ESHRE guideline: recurrent pregnancy loss
|Human Reproduction Open|2018|993
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
|New England Journal of Medicine|2019|945
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
|Blood|2014|840
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
|Nature Immunology|2016|615